March is such an optimistic month. (Although some may wonder this year with the extension of Winter in some parts). It offers a great opportunity to Reflect, Review, and Refocus. As I reflect on the AAOA during Women’s history month, I am…
Targeted Molecular Therapies in Allergy and Rhinology
AAOA’s “Targeted Molecular Therapies in Allergy and Rhinology” (Damask C. et al) was published in the Bulletin.
The past decade has seen a rapid expansion in the use of biologic drugs for the treatment of numerous chronic inflammatory diseases.
Biologic drugs are monoclonal antibodies targeting specific Type ll inflammation molecular pathways for a variety of disease entities in the head and neck.
Read the article here: